Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy

Moran Dvela-Levitt, Maria Kost-Alimova, Maheswarareddy Emani, Eva Kohnert, Rebecca Thompson, Eriene Heidi Sidhom, Ana Rivadeneira, Nareh Sahakian, Julie Roignot, Gregory Papagregoriou, Monica S. Montesinos, Abbe R. Clark, David McKinney, Juan Gutierrez, Mark Roth, Lucienne Ronco, Esther Elonga, Todd A. Carter, Andreas Gnirke, Michelle MelansonKate Hartland, Nicolas Wieder, Jane C.H. Hsu, Constantinos Deltas, Rebecca Hughey, Anthony J. Bleyer, Stanislav Kmoch, Martina Živná, Veronika Barešova, Savithri Kota, Johannes Schlondorff, Myriam Heiman, Seth L. Alper, Florence Wagner, Astrid Weins, Todd R. Golub, Eric S. Lander, Anna Greka

Research output: Contribution to journalArticlepeer-review

Abstract

A small molecule shows promise in clearing misfolded proteins by re-routing them toward lysosomal degradation.

Original languageEnglish
Pages (from-to)521-535.e23
JournalCell
Volume178
Issue number3
DOIs
StatePublished - 25 Jul 2019
Externally publishedYes

Keywords

  • COP vesicles
  • ER stress
  • Golgi apparatus
  • cargo receptor
  • endoplasmic reticulum
  • epithelial cells
  • kidney
  • organoids
  • secretory pathway
  • unfolded protein response

All Science Journal Classification (ASJC) codes

  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy'. Together they form a unique fingerprint.

Cite this